Clinical Trial Product Stocks List Ranked for 2024

Symbol	Grade	Name	% Change
SUPN	F	Supernus Pharmaceuticals, Inc.	0.93
HCM	D	Hutchison China MediTech Limited	1.74
BIIB	C	Biogen Idec Inc.	-1.84
INCY	C	Incyte Corporation	-2.30
LGND	B	Ligand Pharmaceuticals Incorporated	-2.46
LBPH	B	Longboard Pharmaceuticals, Inc.	3.81
HALO	B	Halozyme Therapeutics, Inc.	1.38

Symbol	Grade	Name	Weight
FBT	B	First Trust Amex Biotech Index Fund	11.45
PJP	C	PowerShares Dynamic Pharmaceuticals	10.32
BIS	D	ProShares UltraShort Nasdaq Biotechnology	9.05
IBRN	D	iShares Neuroscience and Healthcare ETF	8.4
PBE	B	PowerShares Dynamic Biotech & Genome	8.37

Compare ETFs

Compare BIS to IBRN Compare FBT to PBE Compare IBRN to PBE

Date	Stock	Title
Jul 3	BIIB	Top Stock Movers Now: Tesla, Paramount Global, Biogen, and More
Jul 3	BIIB	Biogen completes $1.15bn HI-Bio acquisition to expand immunology presence
Jul 3	LBPH	Top 3 Health Care Stocks That May Crash This Quarter
Jul 3	HALO	How Small Biotech Halozyme, With A 41% Run, Is Getting Under Your Skin
Jul 2	INCY	S&P 500 Gains and Losses Today: Index Tops 5,500 as Powell Touts Inflation Progress
Jul 2	BIIB	Eli Lilly Wins Long-Awaited Approval For Biogen-Rivaling Alzheimer's Drug
Jul 2	BIIB	US Equities Markets End Higher Tuesday Following Fed Chair Powell's Comments
Jul 2	BIIB	Biogen (BIIB) Slipped on Lower-Than-Expected Revenue Growth
Jul 2	INCY	Incyte drops as BMO downgrades on $2B buybacks
Jul 2	LBPH	Longboard (LBPH) Up 14% as Epilepsy Drug Gets Breakthrough Tag
Jul 2	BIIB	Biogen Completes Acquisition of Human Immunology Biosciences
Jul 2	INCY	Mesoblast (MESO) Soars 208% YTD on Positive Regulatory Updates
Jul 2	SUPN	Supernus Pharmaceuticals: So-So Neuroscience Portfolio, With ADHD Standout
Jul 2	INCY	Biggest stock movers today: PARA, INCY, and more
Jul 1	LBPH	Longboard Pharmaceuticals Receives Breakthrough Therapy Designation for Bexicaserin (LP352)
Jul 1	LGND	Lifecore Biomedical Announces Cooperation Agreement with 22NW
Jul 1	BIIB	10 clinical trials to watch in the second half of 2024
Jun 28	BIIB	Biogen, Eisai launch Alzheimer's drug Leqembi in China
Jun 28	BIIB	Eisai and Biogen launch LEQEMBI for Alzheimer’s in China
Jun 28	BIIB	Eisai and Biogen launch Alzheimer's drug Leqembi in China

Clinical Trial Product: Clinical trial product is any material used in a clinical trial, including drugs, medical devices, biologics, and other products. Clinical trial products are used to test the safety and efficacy of a new treatment or medical device. Clinical trial products must meet strict regulatory requirements and be approved by the relevant regulatory authorities before they can be used in clinical trials.